San Antonio Breast Cancer Symposium underway
Contact: Elizabeth Allen, 210-450-2020
SAN ANTONIO (Dec. 5, 2013) — More than 7,000 physicians, researchers and advocates will participate this week in the San Antonio Breast Cancer Symposium (SABCS). The annual meeting, Dec. 10-14 at the Henry B. Gonzalez Convention Center, will highlight the latest advances in research and the treatment of breast cancer from around the world.
“We have speakers addressing novel approaches to breast cancer treatment, and also important public health issues such as screening and overdiagnosis,” said Ismail Jatoi, M.D., chief of surgical oncology at The University of Texas Health Science Center at San Antonio. He also is a member of the SABCS Executive Committee.
The SABCS is presented by the university’s Cancer Therapy & Research Center, the American Association for Cancer Research, and Baylor College of Medicine.
Faculty members to lead key panel discussions
CTRC faculty members who will participate include:
The estimated economic impact of the SABCS in 2012 was more than $9 million, with similar figures expected this year.
For more information
To learn more about the SABCS, including registration information and the program, please visit http://www.sabcs.org
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.
HOME [HSC NEWS]
| About UTHSCSA
| News Releases | Mission
Magazine | Grand Rounds Newly
Granted | Submit News | HSC
News Archive | Video Index